reported. The structure elucidation of compound 1 was performed as follows.
The molecular weight of 1 was determined to be 583 by electrospray ionization (ESI)-MS. In its 1 H-NMR spectrum, compound 1 displayed signals of large coupling constants (Jϭ15.5-16.0 Hz) at d 6.35-6.45 and 7.55-7.60, characteristic of the spinning system of the olefinic part of E-pcoumaroyl. The signals of aromatic protons were greatly overlapped. The 13 C-NMR spectrum showed signals attributable to E-p-coumaroyl moieties. The signals at the upper field could be assigned to a spermidine moiety by analysis of its two dimensional (2D) NMR spectrum. The structure of 1 was then deduced to be N 1 ,N 5 ,N 10 -tri-p-coumaroylspermidine. This compound had been reported from the flowers of Crataegus species as a mixture of E and Z forms. The structure had been established by spectral analysis of its permethylated product. 7) Most recently, this compound was isolated from the species of the genera Aphelandra 8) and Helianthus annuus L. 9) However, the 1 H-NMR spectrum of this compound had not yet been assigned clearly. In the present experiment, this compound was isolated as a pure E-form and its 500 MHz 1 H-NMR spectrum could be interpreted by detailed analysis of its 2D NMR spectra. Though the spectrum was considerably complex due to the overlapping and splitting of signals, it revealed that all of the three p-coumaroyl residues were in E-forms and only two conformational isomers were present. As represented by proton signals of 7, 8, 7Ј, 8Ј, 7Љ and 8Љ, the nearer a proton to the center nitrogen, the larger was the split of its signal. This phenomenon indicated that the splitting of signals was mainly due to the sterically hindered umbrella-like inversion at the center N atom. The structure of 1 was further confirmed by synthesis to be N 1 ,N 5 ,N 10 -tri-p-coumaroylspermidine. Compounds 1-4 were tested for their inhibitory activity on HIV-1 PR. In comparing their potent inhibitory activity on HIV-1 integrase and moderate anti-HIV activity, 10,11) 2-4 showed no inhibitory activity against HIV-1 PR. Appreciable HIV-1 PR inhibitory activity was observed only in 1. In addition, the corresponding amine (spermidine) and acid (E-pcoumaric acid) showed no activity against HIV-1 PR. To develop more potent inhibitors, several similar amides were synthesized and tested for their inhibitory activity against HIV-1 PR. Two of the synthesized amides (7, 8) with longer chains, more amide bonds and free hydroxy groups in their p-coumaroyl moieties were found to be more potent HIV-1 PR inhibitors than 1. However, tris(2-p-coumaroylaminoethyl)amine (5) , which possesses the same number of amide bonds as 1, showed no inhibitory activity on HIV-1 PR. On acetylation of hydroxyl groups of the p-coumaroyl residues as in 1a, 7a and 8a, the activity disappeared completely. These polyamides are a new type of HIV-1 PR inhibitors and are easy to synthesize from inexpensive starting materials, which may enable investigaton of their interaction with the enzyme at the molecular level, and conduct of the rational design and synthesis of more preferable inhibitors against HIV-1 PR. Synthesis of Polycoumaroylamines A mixture of E-p-coumaric acid (1.0 g) and Ac 2 O (10 ml) in 10 ml of pyridine was stirred over night at room temperature and worked up as usual to afford 1.1 g of (E)-4-O-acetylcoumaric acid. One gram of (E)-4-O-acetylcoumaric acid in 7 ml of SOCl 2 was refluxed at 80°C for 16 h, then the mixture was evaporated to dryness to give (E)-4-O-acetylcoumaroyl chloride.
To (E)-4-O-acetylcoumaroyl chloride (0.5 mmol) in 15 ml tetrahydrofuran (THF) was added 15 ml THF solution of 0.17 mmol of spermidine [or 0.17 mmol of tris (2-aminoethyl)amine, or 0.13 mmol of spermine, or 0.25 mmol of putrescine, or 0.10 mmol of tetraethylenepentamine], and 100 ml triethylamine. The mixture was stirred at room temperature overnight and then water (20 ml) was added. After being concentrated, the residue was purified with ODS column chromatography eluted with H 2 O-MeOH (6 : 4-0 : 10) to afford the corresponding 4-O-acetylcoumaroylamides (1a, 5a-8a). To a solution of 4-O-acetylcoumaroylamide (50 mg) in CH 3 OH-THF (1 : 1) was added 0.1 N KOH/MeOH 12 ml. After stirring for 1.5 h at room temperature, the solution was neutralized with 0.1 N HCl and purified by ODS column chromatography eluted with H 2 O-MeOH (8 : 2-0 : 10) to give the corresponding coumaroylamides (1, 5-8) . 16H, m, H-2, 3, 5, 6, 8, 9, 11, 12 HIV PR Assay HIV PR assay kit (3700 Horizon Drive, King of Prussia, PA 19406, Kit Lot No 1) was used. Assay was performed and inhibitory activity was calculated as described previously. 14) Acetyl pepstatin was used as a positive control and showed an IC 50 of 0.07 mM.
